Ocular Therapeutix(TM) to Report Third Quarter 2025 Financial Results on November 4, 2025
(NasdaqGM:OCUL), BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans to host a conference call and webcast on Tuesday, November 4, 2025 at 8:00 AM ET to discuss recent business progress and financial results for […]